AL
LIN icon

Aspiriant LLC’s Linde LIN Stock Holding History

Aspiriant LLC’s Portfolio LIN Stock Details LIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508K Buy
978
+467
+91% +$237K 0.01% 244
2026
Q1 		$253K Sell
511
-58
-10% -$27.4K 0.01% 305
2025
Q4 		$243K Buy
569
+60
+12% +$25.7K 0.01% 298
2025
Q3 		$242K Sell
509
-63
-11% -$29.8K 0.01% 275
2025
Q2 		$268K Sell
572
-20
-3% -$9.13K 0.01% 271
2025
Q1 		$276K Sell
592
-49
-8% -$22.1K 0.01% 246
2024
Q4 		$268K Buy
641
+121
+23% +$55.1K 0.01% 247
2024
Q3 		$248K Sell
520
-1
-0.2% -$456 0.01% 254
2024
Q2 		$229K Sell
521
-316
-38% -$139K 0.01% 260
2024
Q1 		$389K Sell
837
-161
-16% -$69.7K 0.02% 220
2023
Q4 		$410K Sell
998
-28
-3% -$11K 0.02% 208
2023
Q3 		$382K Buy
1,026
+18
+2% +$6.85K 0.02% 202
2023
Q2 		$384K Sell
1,008
-385
-28% -$141K 0.02% 197
2023
Q1 		$495K Sell
1,393
-3
-0.2% -$1K 0.03% 176
2022
Q4 		$455K Buy
1,396
+286
+26% +$89.6K 0.02% 183
2022
Q3 		$299K Sell
1,110
-21
-2% -$6.03K 0.01% 211
2022
Q2 		$326K Buy
1,131
+6
+0.5% +$1.87K 0.02% 203
2022
Q1 		$360K Sell
1,125
-42
-4% -$13K 0.02% 203
2021
Q4 		$405K Buy
+1,167
New +$378K 0.02% 194
2019
Q3 		– Sell
-1,448
Closed -$289K – 226
2019
Q2 		$289K Sell
1,448
-353
-20% -$66K 0.02% 183
2019
Q1 		$319K Sell
1,801
-821
-31% -$136K 0.03% 175
2018
Q4 		$407K Buy
+2,622
New +$414K 0.03% 156

Other funds holding LIN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aspiriant LLC's LIN Position: Q2 2026 in Review

Aspiriant LLC increased its Linde (LIN) stake by 91% in Q2 2026, buying an estimated $237K and bringing the position to 978 shares worth $508K. The position accounts for 0.01% of the portfolio, ranked #244.

Aspiriant LLC first reported a position in LIN in Q4 2018 and has held it in 22 quarters since. 2,341 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • Aspiriant LLC held 978 shares of Linde worth $508K as of Q2 2026.
  • Aspiriant LLC bought 467 Linde shares in Q2 2026, an estimated $237K.
  • Linde made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #244 holding.
  • Aspiriant LLC first reported a position in Linde in Q4 2018 and has held it in 22 quarters since.
  • 2,341 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.